Your session is about to expire
← Back to Search
Donor Stool Transplant for Ulcerative Colitis (FMT_UC Trial)
FMT_UC Trial Summary
This trial will test the safety and effectiveness of a new medication for ulcerative colitis.
- Ulcerative Colitis
FMT_UC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFMT_UC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FMT_UC Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You are between the ages of 7 and 21 and have been diagnosed with ulcerative colitis.You require a colonoscopy.You have taken probiotics within the last month before the study.
- Group 1: Patient Stool Transplant
- Group 2: Donor Stool Transplant
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is eligible to take part in this clinical exploration?
"This medical experiment is recruiting 101 individuals aged 7 to 21 with a mild to moderate case of ulcerative colitis, based on their PUCAI score ranging from 10-64. Additionally, these participants must be willing and able to have a colonoscopy conducted."
Are elderly individuals eligible to partake in this scientific experiment?
"Patients aged between 7 and 21 qualify for enrollment in this clinical trial. On the other hand, there are 70 medical studies exclusively for minors below 18 years old, as well as 347 trials designed to serve those 65 or older."
What are the security implications of Donor Stool Transplant for individuals?
"The safety rating of Donor Stool Transplantation is assessed as a 1, due to the preliminary nature of this Phase 1 trial which does not have extensive evidence for either its efficacy or security."
Does the recruitment period for this research endeavor remain open?
"Contrary to expectation, clinicaltrials.gov documents indicate that this medical investigation is not currently recruiting patients; the trial was initially published on November 1st 2016 and last amended on January 30th 2022. Despite this, there are still 408 other trials presently searching for participants."
Share this study with friends
Copy Link
Messenger